DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Motzer RJ, Rini BI, McDermott DF. et al.
Nivolumab for metastatic renal cell carcinoma: results of a randomized phase ii trial.
J Clin Oncol 2015;
33: 1430-1437
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.